Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy

Fusheng Zhang,Jinshuai Guo,Zhenghou Zhang,Yiping Qian,Guang Wang,Meiqi Duan,Haiying Zhao,Zhi Yang,Xiaofeng Jiang

DOI: https://doi.org/10.1016/j.canlet.2021.11.015

2022-02-01

Abstract:Mesenchymal stem cells (MSCs) are multipotent stromal cells that have the ability to differentiate into multiple cell types. Several studies have shown that exosomes secreted by MSCs (MSCs-Exo) play an important role in tumor growth, angiogenesis, invasion, and drug resistance. However, contradictory results have suggested that MSCs-Exo can also suppress tumors through specific mechanisms, such as regulating immune responses and intercellular signaling. Consequently, the relationship between MSCs-Exo and tumors remains controversial. However, it is undeniable that exosomes, as natural vesicles, can be excellent drug carriers and show promise for application in targeted tumor therapy. Here, we review the current knowledge regarding the involvement of MSCs-Exo in tumor progression and their potential as drug delivery systems in targeted therapy. We argue that MSCs-Exo can be used as safe carriers of antitumor drugs.